|
  
Fentanyl-Laced Heroin Demand Reduction Forum
The White House Office of National Drug Control Policy recently convened a forum to bring together law enforcement and public health officials, prevention specialists, and treatment providers from Federal, State, and local governments to discuss the public health threat and response techniques arising from the recent deaths related to fentanyl-laced heroin. More >
AGENDA
FENTANYL-LACED HEROIN DEMAND REDUCTION FORUM
July 28, 2006
Philadelphia, PA
|
9:00 am - 9:10 am | | Welcome (PDF)
Patrick L. Meehan
U.S. Attorney for the Eastern District of Pennsylvania |
|
| 9:10 am - 9:30 am
| | Opening Remarks (PDF)
Dr. Bertha Madras
Deputy Director of Demand Reduction
Office National Drug Control Policy
(20 minutes)
|
|
| 9:30 am - 9:50 am
| | Fentanyl as a Drug of Abuse (PDF)
Dr. Nora Volkow, Director, National Institute on Drug Abuse (15 min. remarks, 5 min. Q & A)
- Pharmacology
- Acute Effects
- Long-term Effects
- Abuse/Addiction Implications
|
|
| 9:50 am - 10:10 am
| | Clandestinely Produced Fentanyl (PDF)
Joe Rannazzisi
Chief, Office of Diversion Control
Drug Enforcement Administration
(15 min., 5 min. Q & A)
- Techniques, Sources & Distribution Trends
- International/Domestic Perspective
|
|
| 10:10 am - 10:50 am
| | Regional Perspectives
|
|
| 10:50 am - 11:00 am
| | Break
|
|
| 11:00 am - 12:00 pm
| | Detecting Overdose Outbreaks: Public Health Surveillance & Considerations
- EMS (PDF)—Captain Richard Bossert, Emergency Medical Services Administration/Continuous Quality Improvement Office, City of Philadelphia (15 minutes)
- Medical Examiners (PDF) —William Wingert, PhD, Chief Toxicologist, Philadelphia Medical Examiner's Office (15 minutes)
- State/Local Health Perspective (PDF)—John Kashani, D.O.
Assistant Medical Director, New Jersey Poison and Information Education System; Assistant Professor, Dept of Preventive Medicine and Community Health, NJMS, UMDNJ. (15 minutes)
- 15 min. Q & A
|
|
| 12:00 pm - 12:45 pm
| | Lunch on own
|
|
| 12:45 pm - 2:00 pm
| | Prevention and Treatment Considerations
- Need for Prevention and Treatment (PDF)—Kenneth Hoffman, MD, MPH, Substance Abuse and Mental Health Services Administration, Division of Pharmacologic Therapies (20 minutes)
- Prevention Specialists (PDF)—Dr. Calvin Trent, PhD, MA, MEd., Director, City of Detroit Bureau of Substance Abuse Prevention, Treatment and Recovery (10 minutes);
Dr. Michelle Reid, Medical Director, Detroit-Wayne County Mental Health Agencies, Detroit Department of Health (10 minutes)
- Treatment Provider—Charles O'Brien, MD, PhD, Kenneth Appel Professor, University of Pennsylvania/VAMC MIRECC (20 minutes)
- Communications Strategy (PDF)—Susan Plaza, Director of Clinical Services, Odyssey House, Inc., New York, NY (15 minutes)
|
|
| 2:00 pm - 2:10 pm
| | Break
|
|
| 2:10 pm - 2:30 pm
| | John P. Walters (PDF)
Director, Office of National Drug Control Policy
|
|
| 2:30 pm - 3:00 pm
| | Media Availability / Audience Q & A
|
|
|
